Applied Clinical Trials
September 01, 2001
Inside IT
CDISC has broad support for its fledgling standard whose evolution is critical to the acceleration of technology adoption in clinical trials.
September 01, 2001
View from Washington
As the public clamors for early access to promising new drugs, sponsors worry about the consequences of experimental therapy conducted outside of controlled trials.
September 01, 2001
View from Brussels
Patients, research companies, and regulatory authorities may all benefit from proposed changes to current pharmaceutical legislation, but the proposals will provoke much debate.
September 01, 2001
Notes from the Field
Readers share their experience
September 01, 2001
Media Review
Michael R. Hamrell, PhD, Ed., (Drugs and Pharmaceutical Sciences, volume 104, Marcel Dekker, New York, 1999), 224 pages, hardcover, ISBN 0-8247-0309-X, $135.
September 01, 2001
Notes from the Field
Readers share their experience
September 01, 2001
Feature Article
Combining the principles of adult learning with the advantages of Web technology can engage participants in important investigator meetings.
September 01, 2001
Feature Article
New systems of ethical oversight for randomized controlled trials could ease the problems caused by increasingly cumbersome restrictions.
September 01, 2001
Feature Article
EN ISO/IEC 17025 is more evidence that international standards are evolving to keep pace with technology and improve the performance of accredited central laboratories.
September 01, 2001
Meet the EAB
As well as being a committed European, Domenico Criscuolo is a powerful supporter of the Italian clinical research community.
September 01, 2001
Feature Article
A creative mobile monitoring model could help sponsors tap the potential of southern Europe (and Mexico) as areas for clinical research.